Slowakije - Slowaaks - ŠÚKL (Štátny ústav pre kontrolu liečiv)

human care hc lifts ab lund Švédsko -

Slowakije - Slowaaks - ŠÚKL (Štátny ústav pre kontrolu liečiv)

human care hc lifts ab lund Švédsko -

Slowakije - Slowaaks - ŠÚKL (Štátny ústav pre kontrolu liečiv)

human care hc lifts ab lund Švédsko -

Slowakije - Slowaaks - ŠÚKL (Štátny ústav pre kontrolu liečiv)

epitope diagnostics, inc. 8940 activity rd., suite g 92126 san diego, california spojené štáty americké -

Slowakije - Slowaaks - ŠÚKL (Štátny ústav pre kontrolu liečiv)

human xtensions ltd. grand netter building, meir ariel strasse 4 4250574 netanya izrael -

Europese Unie - Slowaaks - EMA (European Medicines Agency)

viiv healthcare b.v. - cabotegavir sodium, cabotegravir - hiv infekcie - antivirotiká na systémové použitie - vocabria tablets are indicated in combination with rilpivirine tablets for the short-term treatment of human immunodeficiency virus type 1 (hiv-1) infection in adults who are virologically suppressed (hiv-1 rna.

Europese Unie - Slowaaks - EMA (European Medicines Agency)

astrazeneca ab - chadox1-sars-cov-2 - covid-19 virus infection - vakcíny - vaxzevria is indicated for active immunisation to prevent covid 19 caused by sars cov 2, in individuals 18 years of age and older. použitie tejto vakcíny by mali byť v súlade s oficiálne odporúčania.

Europese Unie - Slowaaks - EMA (European Medicines Agency)

bluebird bio (netherlands) b.v. - elivaldogene autotemcel - adrenoleukodystrophy - Ďalšie lieky na nervový systém - treatment of early cerebral adrenoleukodystrophy in patients less than 18 years of age, with an abcd1 genetic mutation, and for whom a human leukocyte antigen (hla) matched sibling haematopoietic stem cell donor is not available.

Europese Unie - Slowaaks - EMA (European Medicines Agency)

pfizer europe ma eeig  - voxelotor - anemia; anemia, hemolytic; anemia, sickle cell - other hematological agents - oxbryta is indicated for the treatment of haemolytic anaemia due to sickle cell disease (scd) in adults and paediatric patients 12 years of age and older as monotherapy or in combination with hydroxycarbamide.

Europese Unie - Slowaaks - EMA (European Medicines Agency)

merck sharp & dohme b.v. - gefapixant - cough - prípravky proti kašľu a chladu - lyfnua is indicated in adults for the treatment of refractory or unexplained chronic cough.